Merz Pharmaceuticals GmbH
PolandAll drugs from this manufacturer
-
The medicine is used to reduce the severity of Parkinson's disease symptoms (such as stiffness, tremors, decreased motor function, or immobility) and to treat movement disorders resembling Parkinson's disease that have been induced by certain drugs.
Dosage form: tablets, film-coated
Active substance Dosage amantadine sulfate 100 mg ATC: N04BB01
-
The medicine is used to reduce the severity of symptoms of Parkinson's disease and parkinsonian syndromes (such as stiffness, tremors, or movement problems) and in the treatment of movement disorders induced by certain drugs.
Dosage form: tablets, film-coated
Active substance Dosage amantadine sulfate 100 mg ATC: N04BB01
-
The medicine is used to reduce the severity of Parkinson's disease symptoms (such as stiffness, tremors, decreased motor function, or immobility) and to treat movement disorders resembling Parkinson's disease that have been induced by certain medications.
Dosage form: tablets, film-coated
Active substance Dosage amantadine sulfate 100 mg ATC: N04BB01
-
The medicine is used to reduce the severity of Parkinson's disease symptoms (such as stiffness, tremors, decreased mobility, or immobility) and to treat movement disorders induced by certain drugs (e.g., neuroleptics).
Dosage form: tablets, film-coated
Active substance Dosage amantadine sulfate 100 mg ATC: N04BB01
-
The drug helps to remove ammonia from the body and tissues, supporting the liver. It is used in the treatment of hepatic encephalopathy (in acute and chronic liver diseases, such as fatty liver or cirrhosis) and in hyperammonemia.
Dosage form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
-
The medicine helps to remove ammonia from the body and supports the liver. It is used in the treatment of hepatic encephalopathy (in acute and chronic liver diseases, such as fatty liver or cirrhosis) and in hyperammonemia.
Dosage form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
-
The drug is used in the treatment of hepatic encephalopathy resulting from acute or chronic liver diseases (such as cirrhosis or fatty liver) and in hyperammonemia. It helps to remove ammonia from the body and tissues.
Dosage form: solution for infusion, concentrate
Active substance Dosage ornithine aspartate 5 g/10 ml ATC: A05BA
-
It is used in the treatment of latent and overt hepatic encephalopathy occurring in the course of chronic liver diseases, such as cirrhosis or chronic hepatitis.
Dosage form: solution for oral use, granules
Active substance Dosage ornithine aspartate 3 g/5 g ATC: A05BA